Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005 Meeting Abstract
| Authors: | Crinò, L.; Kim, D.; Riely, G. J.; Janne, P. A.; Blackhall, F. H.; Camidge, D. R.; Hirsh, V.; Mok, T.; Solomon, B. J.; Park, K.; Gadgeel, S. M.; Martins, R.; Han, J.; De Pas, T. M.; Bottomley, A.; Polli, A.; Petersen, J.; Tassell, V. R.; Shaw, A. T. |
| Abstract Title: | Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005 |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880302240 |
| DOI: | 10.1200/jco.2011.29.15_suppl.7514 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7514 -- Source: Wos |
